**Core Concept**
Metformin is a biguanide antidiabetic drug that has been shown to be effective in managing type 2 diabetes mellitus, particularly in obese patients. Its mechanism of action involves the inhibition of hepatic gluconeogenesis, which is the process by which the liver produces glucose from non-carbohydrate sources.

**Why the Correct Answer is Right**
Metformin works by activating AMP-activated protein kinase (AMPK), which in turn inhibits the activity of key enzymes involved in gluconeogenesis, such as phosphofructokinase-2 (PFK-2) and fructose-1,6-bisphosphatase. This leads to a decrease in glucose production by the liver and an increase in insulin sensitivity. Metformin is particularly well-suited for obese patients because it does not cause weight gain, unlike some other antidiabetic medications.

**Why Each Wrong Option is Incorrect**
**Option A:** Sulfonylureas, such as glimepiride, stimulate insulin release from the pancreas and can cause weight gain, making them a less ideal choice for obese patients.
**Option B:** Thiazolidinediones, such as pioglitazone, can cause weight gain and fluid retention, which may exacerbate obesity.
**Option C:** SGLT-2 inhibitors, such as canagliflozin, may cause weight loss, but they are not the first-line treatment for obese patients with type 2 diabetes.

**Clinical Pearl / High-Yield Fact**
Metformin is often the first-line treatment for type 2 diabetes due to its effectiveness, safety profile, and lack of weight gain association.

**Correct Answer: A. Metformin**